When I was growing up there was a funny saying, “Take two aspirin and call me in the morning.” Supposedly, that was a typical doctor’s advice. Now, it like the aspirin might be a good idea.
Among adults at high risk of liver cancer, those who took low-dose aspirin were less likely to develop the disease or to die from liver-related causes. The findings come from an analysis published in the New England Journal of Medicine and conducted by a team led by investigators at the Karolinska Institutet, in Sweden, and Massachusetts General Hospital (MGH).
Photo by Anna Shvets on Pexels.com
“Rates of liver cancer and of mortality from liver disease are rising at an alarming pace in U.S. and European countries. Despite this, there remain no established treatments to prevent the development of liver cancer, or to reduce the risk of liver-related death,” said lead author Tracey Simon, MD, MPH, investigator in the Division of Gastroenterology and Hepatology at MGH. Continue reading
Wellness Secrets of a SuperAger 